Advanced search×

Cutaneous fungal granuloma in a horse

Vet Dermatol 20(2):131-134 (2009) PMID 19159411

This case report describes a 4-year-old-horse with two cutaneous masses on the right crest of the neck. Biopsy revealed chronic nodular pyogranulomatous dermatitis and panniculitis. Giemsa and periodic acid-Schiff stains showed focal spherical, yeast-like organisms. A diagnosis of cutaneous fungal granuloma was made. The size of the masses decreased after oral treatment with fluconazole for 10 days combined with potassium iodide for 30 days, and the remaining masses were excised by laser. Lesions did not recur at the site. Fungal granuloma should be considered as a differential diagnosis in horses with cutaneous or subcutaneous nodules. A definitive diagnosis can only be achieved by histopathological examination or by culture of the affected tissue.

DOI: 10.1111/j.1365-3164.2008.00719.x
Version: za2963e q8zae q8zbd q8zc9 q8zd1 q8zed q8zf2 q8zg4

Similar articles you may find interesting…

  1. Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.

    J Vet Intern Med 21(6):1340-6 (2007) PMID 18196745

    I molecules (P = .026) in response to in vitro incubation with rFeIFN-omega, whereas expression of MHC class II molecules was not affected significantly. RFeIFN-omega for the treatment of feline fibrosarcoma is safe, well tolerated, and can be easily performed in practice. To assess...
  2. Keratoconjunctivitis sicca attributable to parasympathetic facial nerve dysfunction associated with hypothyroidism in a horse.

    J Am Vet Med Assoc 233(11):1761-6 (2008) PMID 19046036

    Moderate blepharospasm was evident bilaterally, and both eyes had hyperemic and edematous conjunctivas and lusterless corneas. For each eye, the Schirmer tear test value was only 7 mm/min. The horse's nasal mucosa was dry. Abnormal behaviors included mild repetitive vertical movement of the head, sn...
  3. Catumaxomab: malignant ascites: unjustified marketing authorisation.
    Author(s) unavailable

    Prescrire Int 19(109):207-9 (2010) PMID 21180374

    The only treatment for malignant ascites in patients with refractory cancer is paracentesis, a procedure to relieve symptoms. Catumaxomab, a monoclonal antibody, is now authorised in the European Union for intraperitoneal administration to patients with epithelial cancers that overexpress epithelial...